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In eukaryotic cells, there are several post-transcriptional modification steps such
as RNA editing and alternative splicing, until mRNA molecules are fully ma-
tured and translated into proteins. Thus, the transcriptome is a complex mix-
ture of various intermediates that are processed in multiple steps. This complex
regulatory structure makes it difficult to fully understand the landscape of tran-
scriptome. My doctoral study consists of three studies that enable RNA-seq to
be decoded and utilized in terms of RNA editing, alternative splicing, and gene
expression.
RNA editing is a post-transcriptional RNA sequence modification performed
by two catalytic enzymes ADAR (A-to-I) and APOBEC (C-to-U). RNA editing
is considered an important regulatory system that controls a variety of cellular
i
functions such as protein activation, alternative splicing, and miRNA target-
ing. Therefore, detecting RNA editing events in RNA-seq data is important for
understanding its biological functions. However, it is known that a significant
amount of false-positives occur when detecting RNA editing in RNA-seq. Since
it is not possible to experimentally validate all RNA editing residues extracted
from RNA-seq, a computational model is needed to filter potential false-positive
RNA editing calls. RDDpred, an RNA editing predictor based on machine learn-
ing techniques, was developed to filter out false-positive RNA editing calls in
RNA-seq. It uses prior knowledge bases to collect training instances directly
from the input data, and then trains the random forest (RF) predictors that
are specific to the input data. RDDpred was tested using two publicly available
datasets of RNA editing studies and has shown good performance.
Another complex problem in RNA-seq decoding is spliceomic intratumor
heterogeneity (ie, sITH). Intratumor heterogeneity (ITH) represents the diver-
sity of cell populations that make up the cancer tissue. Recent studies have
identified ITH at the transcriptome level and suggested that ITH at gene ex-
pression levels is useful for predicting prognosis. Measuring ITH levels at the
spliceome level is a natural extension. There is a serious technical challenge in
measuring sITH from bulk tumor RNA-seq, such as complex splicing patterns,
widespread intron retentions, and short sequencing read lengths. SpliceHetero,
an information-theoretic method for measuring the sITH of a tumor, was de-
veloped to address the aforementioned technical problems. SpliceHetero was
extensively tested in experiments using synthetic data, xenograft tumor data
and TCGA pan-cancer data and measured sITH successfully. Also, sITH was
shown to be closely related to cancer progression and clonal heterogeneity, along
with clinically significant features such as cancer stage, survival outcome, and
PAM50 subtype.
ii
The last research topic is to develop a machine learning algorithm that de-
fines patient subspaces specific to particular cancer phenotypes based on gene
expression data. Since RNA-seq data is high-dimensional data composed of
20,000 or more genes in general, it is not easy to apply a machine learning
algorithm. A network that collects information of experimentally verified inter-
action of proteins is called a Protein Interaction Network (PIN). Tumor2Vec
defines the patient subspace by defining the subnetwork communities that in-
teract with each other by applying the Graph Embedding technique to PIN.
Tumor2Vec proposed a clinical model by defining a subspace for patients with
different lymph node metastases in early oral cancer and found biologically
significant features in the PIN subnetwork unit in the process.
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In eukaryotic cells, there are several post-transcriptional modification steps,
such as alternative polyadenylation, RNA editing, and alternative splicing be-
fore mRNA molecules are fully matured and translated into proteins (Figure
1.1) (Xiang et al., 2018). Thus, the transcriptome is a complex mixture con-
taining various transcriptomic variations that are regulated by different mod-
ification systems. This complex regulatory structure makes it difficult to fully
understand the landscape of transcriptome.
High throughput RNA sequencing (RNA-seq) is a technology that provides
a comprehensive profile of the whole transcriptome by reading vast amounts of
RNA fragments (Figure 1.2) (Haas and Zody, 2010). Thus, RNA-seq has been
used to elucidate associations between biological phenotypes and transcriptomic
variations such as gene expression, RNA editing, and alternative splicing. Each
of the three transcriptomic variations has been actively studied and found to
be associated with a variety of biological phenotypes.
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Figure 1.1: A description of the post-transcriptional modification process in
eukaryotes (Xiang et al., 2018).
1.1 Biological background
RNA editing
RNA editing is a post-transcriptional RNA sequence modification performed by
two catalytic enzymes ADAR (A-to-I) and APOBEC (C-to-U). RNA editing is
considered an important regulatory system for controlling various cell functions
such as protein activity, alternative splicing, and miRNA targeting (Figure 1.3)
(Licht and Jantsch, 2016). There are also several studies showing the direct rela-
tionship between RNA editing and biological phenotypes. The study by Galeano
et al. suggested that specific RNA editing patterns in glioblastomas by ADAR2
enzymes are crucial for the pathogenesis and that ADAR-class enzymes can be
considered as tumor suppressors (Galeano et al., 2013). It is also known that
APOBEC3G, a type of APOBEC-class enzyme, causes HIV-1 retroviral inac-
tivation by deamination (Chiu et al., 2010). Therefore, detecting RNA editing
2
Figure 1.2: A description of RNA-seq data (Haas and Zody, 2010).
events in RNA-seq data is important for understanding the association between
RNA editing patterns and biological phenotypes.
Alternative splicing
Alternative splicing is another important post-transcriptional modification that
greatly increases the diversity of proteins that can be expressed from a limited
number of genes (Liu et al., 2017). The aggregate of cell splicing information
is often referred to as spliceome. The term spliceome was coined around 2000
to describe the set of all possible alternatively spliced mRNA and proteins in
an organism and all the species depending on the context. Recent studies have
3
Figure 1.3: A schematic of the intracellular regulatory system governed by RNA
editing (Licht and Jantsch, 2016).
suggested associations between cancer phenotypes and spliceomic variations,
which can be caused by splice site mutations and malfunctioning splicing factors
(Figure 1.4) (Climente-González et al., 2017). RNA-seq is the most effective
tool for quantifying spliceome due to its comprehensive profiling capabilities.
Many recent spliceome studies have used RNA-seq to understand the biological
implications of alternative splicing (Sebestyén et al., 2016; Tsai et al., 2015).
Gene expression
RNA-seq is also a powerful tool that provides gene expression profiles of cells.
It uses random primer technology to provide a de novo capture of transcripts
without relying on pre-designed probes, which is not possible with microarrays.
Because of its high throughput capacity and high resolution, many studies have
explored the relationship between biological phenotypes and gene expression
patterns using RNA-seq (Figure 1.2) (Haas and Zody, 2010).
4
Figure 1.4: A schematic of the intracellular regulatory system governed by RNA
editing (Licht and Jantsch, 2016).
1.2 Challenges in decoding and utilizing RNA-seq data
There are challenges in decoding and utilizing RNA-seq data in each of the
three transcriptomic domains (ie, gene expression, RNA editing, and alternative
splicing). The challenges in each of the transcriptomic domains are summarized
as follows.
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1.2.1 false-positives in RNA editing calls
It is known that a significant amount of false-positives occurs when detecting
RNA editing in RNA-seq. In 2012, Nature Biotechnology published an interview
with eight prominent RNA editing researchers in an article called “The difficult
calls in RNA editing” (Bass et al., 2012). All eight researchers have pointed out
that false-positives are one of the biggest challenges in detecting RNA editing
using RNA-seq. They also mentioned that one of the major causes of false-
positives is mis-mapping during RNA-seq alignment.
An in silico experiment, part of a preliminary study discussed in Chapter
2, also suggested that mis-mapping poses a significant risk of false-positives
(Figure 2.2). Since it is not possible to experimentally validate all RNA editing
residues extracted from RNA-seq, a computational model is needed to filter
potential false-positive RNA editing calls.
1.2.2 Absence of a model for measuring spliceomic intratumor
heterogeneity considering complex cancer spliceome
Intratumor heterogeneity (ITH) represents the diversity of cell populations that
make up cancer tissue (Boland and Goel, 2005). This is the result of a subclone
diversification process during cancer progression, which is considered a form of
Darwinian evolutionary process (Nowell, 1976). The level of ITH reflects the
genetic diversity of bulk tumors, which generally have a negative correlation
with prognosis. An explanation for this trend is that the genetic diversity pro-
vided by ITH can be an accelerator of somatic cell evolution that helps cancer
cells acquire a malignant phenotype (Marusyk and Polyak, 2010; Greaves and
Maley, 2012; Sun and Yu, 2015; McGranahan and Swanton, 2017).
In a recent study by Morris et al. (Morris et al., 2016), ITH of each cancer
sample was first calculated using genomic features such as copy number varia-
6
Domain Variation Method
Genomic CNVs, Somatic mutations Mathematical modeling
Methylomic Methylation Mathematical modeling
Transcriptomic Expressional difference Information theory
Spliceomic Alternative splicing None
Table 1.1: Description of each approach using various molecular domains.
tion (CNV) and somatic mutation. Then, the relationship between ITH of each
cancer sample and various clinical characteristics was tested. They concluded
that the level of ITH in each cancer sample was significantly associated with
the molecular, pathologic, and clinical characteristics including prognosis.
ITH can be deduced using molecular profiles of various domains such as
genome, epigenome and transcriptome domain. Approaches using each domain
have been used to assess the level of ITH in cancer tissues and to identify molec-
ular features associated with tumor evolution (Table 1.1). For example, two ITH
studies using genomic variation have revealed somatic mutations that are closely
related to tumor evolution in various types of cancer (Carter et al., 2012; Roth
et al., 2014). Methylomic and transcriptomic (gene expression) methods for
measuring ITH in bulk tumors have been developed and identified important
molecular features (Mazor et al., 2016; Park et al., 2016).
The presence of intercellular spliceomic differences has been suggested by
studies published over the past decade (Rajan et al., 2009; Wan and Larson,
2018). A recent single-cell study showed that there is a clear difference in the
use of isoforms in bone marrow-derived dendritic cells (Shalek et al., 2013).
The clinical effect of spliceomic ITH (ie, sITH) has not been thoroughly studied
because there is no available sITH model.
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There are serious technical challenges in measuring sITH from bulk tumor
RNA-seq. A recent study has reported the widespread intron retention of cancer
cells (Dvinge and Bradley, 2015), suggesting that the isoform of cancer cells is
very complex and not yet characterized. This means that a significant amount of
unexpected splice junctions can be found in the cancer sample (Eswaran et al.,
2013). To handle these unexpected splice junctions, a transcriptome assembly
is required to account for previously unknown isoforms. However, prevalent
splice-site mutations (Jayasinghe et al., 2018) and short sequence reads in RNA-
seq make it difficult to perform transcriptome assembly. Therefore, a model is
needed to avoid this difficulty and to measure sITH in bulk tumor.
1.2.3 Lack of biological interpretation of dimension reduction
techniques using gene expression
Transcriptome analysis using RNA-seq is considered to be one of the most effec-
tive tools for revealing the underlying biological mechanisms of various cancer
phenotypes (Kumari et al., 2017; Lin et al., 2018; Jardim-Perassi et al., 2019).
RNA-seq produces a comprehensive expression level of each gene, including
more than 20,000, in the case of the human genome. The high resolution of
RNA-seq is both an advantage and a cause of trouble at the same time. This
problem is also known as high dimension low sample size data problem (McGet-
tigan, 2013; Shen et al., 2016).
There are several machine learning based solutions that address dimensional
reduction problems such as Principal Component Analysis (PCA) (Minka, 2001),
Latent Dirichlet Allocation (LDA) (Hoffman et al., 2010), Nonnegative Matrix
Factorization (NMF) (Cichocki and Phan, 2009), Isomap (Tenenbaum et al.,
2000), Locally Linear Embedding (Roweis and Saul, 2000), Multi Dimensional
Scaling (MDS) (Kruskal, 1964), Spectral Embedding (Ng et al., 2002), and
8
t-Stochastic Neighbor Embedding (t-SNE) (Maaten and Hinton, 2008).
Since the existing dimension reduction techniques are unsupervised, the re-
sulting embedding does not reflect the differences between sample labels. Given
that the vast majority of cases using RNA-seq are looking for transcriptomic
differences between samples with different conditions, these unsupervised ap-
proaches do not meet those needs. Also, since the resulting embedding generated
by these approaches is generally not provided with a biological interpretation,
users must re-process the results in their own way. In this process, the same
result is often interpreted differently. Therefore, a supervised learning model is
needed that can directly derive the biological interpretation from the resulting
embedding.
1.3 Machine learning techniques to solve difficulties
in using RNA-seq
• RDDpred, a condition-specific machine learning model for filtering false-
positive RNA editing calls in RNA-seq data, was developed to filter out
false-positive RNA editing calls in RNA-seq. It uses prior knowledge bases
to collect training examples directly from the input data, eliminating the
need for expensive experimental verification.
• SpliceHetero, an information-theoretic approach for measuring spliceomic
intratumor heterogeneity from bulk tumor RNA-seq data, was developed
to solve technical problems caused by complex cancer spliceome. It uses
a local analysis approach to avoid transcriptome assemblies that are not
easily achievable in cancer spliceome.
• Tumor2Vec, a supervised learning algorithm for extracting subnetwork
representations of cancer RNA-seq data using protein interaction net-
9
works, was developed. It uses the graph embedding technique applied
to the PIN to determine the globally well-tuned local subnetwork com-
munity. Each community is then considered a feature representation of
the input data. It uses machine learning techniques to reduce the dimen-
sionality of RNA-seq data while providing interpretable subnetwork level
features.
1.4 Outline of thesis
My doctoral study consists of three studies that enable RNA-seq to be decoded
and utilized in terms of RNA editing, alternative splicing, and gene expression.
Chapters 2, 3, and 4 introduce independent studies on how to deal with the
difficulties of using RNA-seq in each of the three transcriptomic domains.
Chapter 2 describes RDDpred, a condition-specific machine learning model
for filtering false-positive RNA editing calls in RNA-seq data, which aims at
filtering false-positive RNA editing calls in RNA-seq. Chapter 3 discusses Splice-
Hetero, an information-theoretic approach for measuring spliceomic intratumor
heterogeneity from bulk tumor RNA-seq, which aims to develop a sITH model
that takes into account the technical challenges of complex cancer spliceome.
Chapter 4 discusses Tumor2Vec, a supervised learning algorithm for extracting
subnetwork representations of cancer RNA-seq data using protein interaction
networks, which aims to reduce the dimension of RNA-seq data while providing
interpretable subnetwork level features.
Chapter 5 summarizes the results of previous studies and the expected re-




RDDpred: A condition specific
machine learning model for
filtering false-positive RNA
editing calls in RNA-seq data
2.1 Related works
There are three types of methods for dealing with false-positives in RNA editing
calls. 1) Prior knowledge-based filtering, 2) Mapping error prone site estimation,
and 3) Machine learning based predictor.
• Prior knowledge-based filtering is the most stringent of all. It collects all
potential genomic loci that can cause mis-mapping and excludes all RNA
editing residues found nearby (Li et al., 2009; Mo et al., 2014).
• Mapping error prone site estimation is a proactive approach that pre-
locates genomic loci that are prone to mapping errors and excludes RNA
editing residues from the loci (Peng et al., 2012). To find such loci, they
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first synthesize RNA-seq, in which mismatches are intentionally inserted.
The generated RNA-seq is mapped to the genome sequence to be evalu-
ated. As a result, mismatches found in areas other than those that were
intended at the time of data generation are classified as sites that are
prone to mapping errors (Figure 2.1).
• Machine learning-based predictor is a method of using machine learning
algorithms to learn the difference between true and false-positive examples
and then to determine candidate residues based on the learned model
(St Laurent et al., 2013; Zhang and Xiao, 2015).
2.2 Motivation
Compared to the other two approaches, prior knowledge based filtering is rela-
tively näıve and has suspicious performance (Li et al., 2009; Mo et al., 2014).
Mapping error prone site estimation has shown better performance (Peng et al.,
2012), but it is impossible to simulate all possible conditions. Therefore, it lacks
generality. The machine learning-based predictor approach does not suffer from
this problem because it can generate generic predictors from training examples
(St Laurent et al., 2013; Zhang and Xiao, 2015). Also, according to a study
by St. Laurent et al., the predictive accuracy of the machine learning model is
quite high (87%) (St Laurent et al., 2013).
One problem with using machine learning approaches in RNA editing calls
is that current approaches require experimentally proven RNA editing sites to
generate models. Proactively verifying as many sites as necessary for a machine
learning model is costly and is not possible if there are not enough samples.
Therefore, a machine learning method is required to obtain training examples
directly from input data without experimental verification.
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Figure 2.1: A flowchart for the mapping error prone site estimation process
(Peng et al., 2012). Mapping error prone sites (MES) are calculated as follows:
1) RNA-seq data with intentionally inserted mismatches are synthesized. 2) The
synthesized RNA-seq is mapped to the genome sequence. 3) After SNV call, mis-
matches found in unintended areas are classified as MES sites.
2.3 A preliminary study
The human genome has lots of loci with mis-mapping risks such as inherent du-
plicates and repeats, splice sites, and individual polymorphisms. And the short
sequence read length of RNA-seq makes all of this worse (Degner et al., 2009;
Heap et al., 2010; Engström et al., 2013). A preliminary study was conducted
to evaluate the impact of mis-mapping on false-positive RNA editing calls. The
test process is as follows (Figure 2.2).
1. Ten RNA-seq data were synthesized, each with 10 million paired-end reads
(100bp x 2). Where random single nucleotide variations (SNVs) were in-
serted with a 1% probability for each read. The inserted 1% SNVs rep-
resent individual genetic differences, such as individual SNPs, somatic
mutations, and RNA editing.
2. RNA-STAR (Dobin et al., 2013), a state-of-the-art alignment tool in terms
of base accuracy (Engström et al., 2013), was used to align the RNA-seq
data with the human genome (hg19 build).
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Figure 2.2: A schematic of the preliminary test process.
Mapped Reads Mapped Residues Raw SNVs false-positives Standard Caller Failed
ITER 1 9,734,787 80,552,288 8,872,433 8,358,426 350,694
ITER 2 9,735,558 80,558,479 8,878,304 8,365,007 350,670
ITER 3 9,733,473 80,568,898 8,880,681 8,366,553 350,136
ITER 4 9,733,159 80,570,416 8,879,502 8,365,311 350,442
ITER 5 9,733,939 80,545,810 8,853,408 8,339,822 350,332
ITER 6 9,733,507 80,542,007 8,838,870 8,326,074 350,917
ITER 7 9,734,222 80,555,307 8,859,741 8,346,628 350,390
ITER 8 9,735,046 80,562,701 8,874,369 8,361,655 350,807
ITER 9 9,733,971 80,555,609 8,852,720 8,339,866 350,059
ITER 10 9,734,717 80,542,143 8,863,065 8,350,655 350,809
AVG 9,734,238 80,555,366 8,865,309 8,352,000 350,526
Table 2.1: A table for preliminary test results.
3. Standard SNV callers such as samtools (Li, 2011) and GATK (McKenna
et al., 2010) have been applied to filter out false-positives in the results.
Table 2.1 summarizes the preliminary test results. On average, 10 million
reads result in 8.35 million false-positive residues. Of these, 350,000 residues
(4.20%) could not be filtered by overlapping two standard SNV callers (ie,
samtools and GATK). The result suggests that when producing 10 million RNA-
seq reads to detect RNA editing, there is a risk of 350,000 false-positives on
average, which are difficult to filter with standard SNV callers.
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2.4 Methods
RDDpred uses prior knowledge bases to extract positive and negative training
examples from input data. The whole process is as follows (Figure 2.3).
Input preparation
The RNA-seq data must be properly aligned and converted to BAM file format
for input to RDDpred. After receiving the RNA-seq data, RDDpred processes
each data using the built-in standard SNV caller samtools-bcftools (Li, 2011).
SNVs detected by the standard SNV caller samtools-bcftools are considered
candidates for RNA editing.
Preparation of positive training examples
There are two well-organized RNA editing databases called DARNED (Kiran
and Baranov, 2010) and RADAR (Ramaswami and Li, 2013). RDDpred queries
each RNA editing candidate for each database and considers the residues con-
tained in the database as positive examples.
Preparation of negative training examples
As mentioned, mis-mapping is a major cause of false-positives in RNA editing
calls (Bass et al., 2012). Therefore, RDDpred prepares negative training exam-
ples using the mapping error prone site estimation method (Figure 2.1) (Peng
et al., 2012).
Input feature description
RDDpred constructs a random forest model using 15 features that reflect the
local read alignment pattern. The local read alignment pattern is the local state
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of the alignment near the SNV. There are at least six categories of attributes
calculated from local read alignment patterns such as Read Depth, Allele Segre-
gation, Mapping Quality, Read Position, Base Quality, and Read Strand. The
samtools-bcftools pipeline provides 15 statistics in six categories (Table 2.2).
Each of the 15 features in the six categories has the following meanings.
• The Read Depth category contains the ReadDepth attribute, which indi-
cates the number of RNA-seq reads that cover each SNV residue.
• The Allele Segregation category contains four attributes, including VAF,
SGB, FQ, and CallQual, and is calculated based on the allele ratio of each
SNV.
• The Mapping Quality category includes four attributes, PV3, MQB, MQ0F,
and MQ, which are calculated based on the quality of the mappings gen-
erated by the aligner and generally indicate whether the reads are multi-
mapped.
• The Read Position category contains three attributes, including VDB,
RPB, and PV4, which indicate how the relative position of the SNV is
biased for each RNA-seq read. When overly biased, it usually indicates a
mis-mapping.
• The Base Quality category includes two attributes, PV2 and BQB, which
indicate whether the low-quality base is highly biased for each SNV, where
the base quality is evaluated by the sequencing machine.
• The Read Strand category contains the PV1 attribute, which indicates
how biased the strand of the read with the SNV is.
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Category Name Description
Read Depth ReadDepth Read depth
Allele Segregation VAF Variant read ratio
Allele Segregation SGB Segregation based metric
Allele Segregation FQ Phred probability of all samples being the same
Allele Segregation CallQual Variant/reference QUALity
Mapping Quality PV3 Mapping quality bias
Mapping Quality MQB Mann-Whitney U test of Mapping Quality Bias
Mapping Quality MQ0F Fraction of MQ0 reads
Mapping Quality MQ Root-mean-square mapping quality of covering reads
Read Position VDB
Variant Distance Bias for filtering splice-site artefacts in
RNA-seq data
Read Position RPB Mann-Whitney U test of Read Position Bias
Read Position PV4 Tail distance bias
Base Quality PV2 Base quality bias
Base Quality BQB Mann-Whitney U test of Base Quality Bias
Read Strand PV1 Read strand bias
Table 2.2: A table for the 15 input variables used in the Random Forest model.
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Figure 2.3: A flowchart of total workflow for RDDpred.
2.5 Results
2.5.1 Design of experiments for evaluation
RDDpred was evaluated using the results of two previous studies conducted by
Bahn et al. and Peng et al., respectively (Peng et al., 2012; Bahn et al., 2012).
Both studies computationally predicted RNA editing sites and validated them
with Sanger-seq. The details of the two studies are as follows.
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• In the study by Bahn et al. (SRA accession: SRP009659), they collected
samples of human glioblastoma astrocytoma and generated 115,132,348
RNA-seq reads. After processing the reads, they predicted 4,141 RNA
editing residues as true editing, of which 47 residues were tested with
Sanger-seq. They found that 19 residues (40.43%) were false-positives.
• In the study by Peng et al. (SRA accession: SRP007605), they collected
samples of human lymphoblastoid and generated 583,640,030 RNA-seq
reads. After processing the reads, they predicted 22,688 RNA editing
residues as true editing, of which 123 residues were tested with Sanger-seq.
They found that 29 residues (23.58%) were false-positives.
2.5.2 Evaluation using data from Bahn et al.
RDDpred detected 6,856,440 RNA-DNA differences (RDD) as a result of pri-
mary detection in the 115,132,348 RNA-seq reads produced by Bahn et al. Here,
RDD means SNV not found in matched DNA-seq but found only in RNA-
seq. RDDpred filtered 6,750,876 residues (98.46%) and predicted the remaining
105,564 residues as true editing.
Overall, the RDDpred results included 3,947 (95.32%) of the 4,141 residues
reported by Bahn et al. In the residues tested with Sanger-seq, the result con-
tained 18 of the 47 residues (38.30%), of which 3 were false-positives (16.67%)
(Table 2.3).
2.5.3 Evaluation using data from Peng et al.
RDDpred detected 58,666,976 RNA-DNA differences (RDD) as a result of pri-
mary detection in the 583,640,030 RNA-seq reads produced by Bahn et al. Here,
RDD means SNV not found in matched DNA-seq but found only in RNA-
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Bahn et al. RDDpred Accept RDDpred Reject Sum
True Positive 15 13 28
false-positive 3 16 19
Sum 18 29 47
Table 2.3: A table for evaluation results using data of Bahn et al.
Peng et al. RDDpred Accept RDDpred Reject Sum
True Positive 73 21 94
false-positive 7 22 29
Sum 80 43 123
Table 2.4: A table for evaluation results using data of Peng et al.
seq. RDDpred filtered 6,750,876 residues (94.76%) and predicted the remaining
3,076,908 residues as true editing.
Overall, the RDDpred results included 20,504 (90.37%) of the 22,688 residues
reported by Peng et al. In the residues tested with Sanger-seq, the result con-
tained 80 of the 123 residues (65.04%), of which 7 were false-positives (8.75%)
(Table 2.4).
2.6 Discussion
Evaluation using the results of previous two studies
Overall, the RDDpred results included most of the residues reported in the
two studies (Bahn: 95.32%, Peng: 90.37%). This means that RDDpred has
successfully reproduced their results. Also, RDDpred results in residues tested
with Sanger-seq contained significantly fewer false-positives compared to the
residues reported in each study (Bahn: 40.43% ⇒ 16.67%, Peng: 23.58% ⇒
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8.75%). This means that RDDpred has more robust performance than previous
approaches. Note that in both comparisons, the residues tested with Sanger-seq
were excluded from the training phase of RDDpred for a fair comparison.
Evaluation of feature importance
The 15 input features were evaluated for their ability to distinguish false-
positive RNA editing calls. They were evaluated by calculating the information
gain using WEKA (Hall et al., 2009). Table 2.5 summarizes the evaluation re-
sults. The top five features are contained in two categories, Allele Segregation,
and Base Quality. Allele Segregation represents the number of reads that sup-
port SNV, and Base Quality represents the quality of sequencing generated by
the sequencing machine (Li, 2011). It means that the most important features
distinguishing true and false-positive RNA editing are the SNV allele ratio and
the base quality evaluated by a sequencing machine.
Software specification
RDDpred was developed as a software package with WEKA, a data mining
package, to train a prediction model (Hall et al., 2009). The Random Forest
algorithm was chosen because it showed a good performance in the study by St.
Laurent et al. (St Laurent et al., 2013). RDDpred was tested in a Linux envi-
ronment with Python (2.7.3), Samtools-Bcftools (1.2.1), and WEKA (3.6.12).
RDDpred can get input from any type of alignment method that provides BAM
format output. However, RNA-STAR is recommended for high overall accuracy
and high performance (Engström et al., 2013; Dobin et al., 2013). RDDpred is
available free of charge at http://biohealth.snu.ac.kr/software/RDDpred/.
Also, to provide information about actual execution time and memory usage,
RDDpred tested with the data of Peng et al. (Peng et al., 2012). RDDpred took
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Category Name Bahn et al. Peng et al. Avg. Rank
Allele Segregation FQ 0.6124 0.3319 2
Base Quality PV2 0.4746 0.4611 3
Allele Segregation VAF 0.5526 0.3268 3.5
Allele Segregation CallQual 0.5737 0.1958 4
Base Quality BQB 0.425 0.3428 4
Read Depth ReadDepth 0.4943 0.2515 4.5
Read Position PV4 0.234 0.1615 7.5
Read Position RPB 0.2545 0.0712 8.5
Read Position VDB 0.0988 0.073 9.5
Mapping Quality MQ0F 0 0.0785 11
Allele Segregation SGB 0.0932 0.0368 11.5
Read Strand PV1 0.1584 0.0216 11.5
Mapping Quality MQ 0 0.0591 12.5
Mapping Quality MQB 0.0401 0.0367 12.5
Mapping Quality PV3 0 0.0137 14.5
Table 2.5: A table for input feature evaluation results.
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18.33 hours to process 583,640,030 of 101,787,059,720 bases, which is a level that
does not hinder the general bioinformatics study. The machine specifications
specified in the experiment are as follows.
• Linux version: Linux version 2.6.32-358.el6.x86 64, CentOS release 6.4
• Memory usage: 20GB in maximum
• CPU usage: 20 cores (Intel(R) Xeon(R) CPU E5645 @ 2.40GHz)
2.7 Conclusion
There are limitations to existing methods such as non-machine learning meth-
ods lacking generality and machine learning methods requiring extensive proac-
tive experimental validation. RDDpred is a machine learning technique that
overcomes these limitations. It uses prior knowledge bases to extract training
samples directly from the input data and then generates machine learning pre-
dictors specific to the input conditions. This condition-specific nature makes
the model generally have good performance. RDDpred was tested using the re-
sults of two previous studies and showed good results by significantly reducing







heterogeneity from bulk tumor
RNA-seq data
3.1 Related works
ITH can be deduced using molecular profiles of various domains such as genome,
epigenome and transcriptome domain. Approaches using each domain have been
used to assess the level of ITH in cancer tissues and to identify molecular
features associated with tumor evolution (Table 1.1). For example, two ITH
studies using genomic variation have revealed somatic mutations that are closely
related to tumor evolution in various types of cancer (Carter et al., 2012; Roth
et al., 2014). Methylomic and transcriptomic (gene expression) methods for
measuring ITH in bulk tumors have been developed and identified important
molecular features (Park et al., 2016; Mazor et al., 2016).
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Genome-level ITH has been extensively studied using bulk tumor sequenc-
ing data. ABSOLUTE (Carter et al., 2012) is a genomic ITH model that uses
somatic cell mutations and CNV profiles of bulk tumors to infer ITH. ABSO-
LUTE estimated the optimal values of cancer purity and ploidy using a linear
programming technique and then estimated the subclonal genome fraction (ie,
ITH). A slightly different approach was used in PyClone (Roth et al., 2014).
PyClone used the Bayesian model to define the generative relationship between
the number of subclones and the observed genomic variation and then used the
Bayesian clustering algorithm to select the optimal number of subclones that
best fit the observed data.
Recently, an ITH model using a methylation profile was developed. Methyla-
tion does not alter the DNA sequence but is linked to genomic DNA. Thus, the
DNA methylation pattern has similar characteristics to the genomic variants.
For example, both consider both alleles of each locus corresponding to each
pair of homologous chromosomes. When bisulfite-seq is used, the methylated
base detection process is similar to somatic mutation. Thus, the methylomic
ITH (or mITH) model proposed by Mazor et al. used a mathematical modeling
approach similar to the genomic profile based model (Mazor et al., 2016)
A transcriptome-level ITH model was recently developed (Park et al., 2016).
They used information theory to estimate ITH in bulk tumors. They proposed
an interesting idea to consider ITH as the difference in gene expression dis-
tribution between normal tissue and bulk tumors. They first used a curated
database of molecular pathways, such as the KEGG database (Kanehisa et al.,
2016), to construct a template network and construct a probability distribu-
tion for each pathway. The divergence between normal tissue and bulk tumor
samples is then calculated by the average Jensen-Shannon Divergence (JSD) of
each probability distribution for each pathway. This divergence was considered
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to be transcriptomic ITH (tITH) for each sample and was found to be related
to clonal evolution and prognostic features.
The presence of intercellular spliceomic differences has been suggested by
studies published over the past decade (Rajan et al., 2009; Wan and Larson,
2018). A recent single-cell study showed that there is a clear difference in the
use of isoforms in bone marrow-derived dendritic cells (Shalek et al., 2013).
The clinical effect of spliceomic ITH (ie, sITH) has not been thoroughly studied
because there is no available sITH model.
3.2 Motivation
Bulk tumor RNA sequencing
In this study, ITH was measured using bulk tumor RNA-seq data. bulk tu-
mor RNA-seq is a technique that combines bulk sampling with short-read se-
quencing. A possible alternative for each part is single-cell analysis and single-
molecule real-time sequencing (SMRT-seq).
Single-cell analysis has been improved in terms of stability and efficiency
and has been used in many biological studies. This technique is very useful
for studying ITH because it provides a molecular profile of each cell composed
of bulk tumors (Patel et al., 2014). However, due to patient-to-patient het-
erogeneity, the reproducible cancer model requires extensive study of a large
group of patients. Thus, a single-cell approach is not feasible in this case. An-
other technology, SMRT-seq, is attracting much attention because of its long
read length and lack of bias due to cDNA amplification. However, sequencing
errors in SMRT-seq are still a problem and production costs are still very high.
Currently, major cancer consortia such as TCGA produce only bulk tumor
RNA-seq data. It is therefore difficult to obtain data with adequate clinical
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information using the SMRT-seq platform or single-cell platform. Thus, this
study focused primarily on bulk tumor RNA-seq.
Difficulty in measuring spliceomic ITH
Since Park et al. (Park et al., 2016) proposed a good model for ITH at the RNA
level, spliceomic ITH (ie, sITH) is naturally defined by extending their method.
However, there are serious technical difficulties in extending their method to
sITH. First, tITH model by Park et al. (Park et al., 2016) requires a template
network to create a probability distribution that can not be used in this case.
Also, a recent study has reported the widespread intron retention of cancer cells
(Dvinge and Bradley, 2015), suggesting that the isoform of cancer cells is very
complex and not yet characterized. This problem is more difficult to solve due
to the short length of the RNA-seq read.
If you can assemble full-length transcripts from RNA-seq reads, measur-
ing spliceomic ITH will be much easier, even with cancer cells with complex
isoform patterns. However, due to the limited length of the RNA-seq read (<
200-bp), it is very difficult to assemble the entire transcript where all possible
combinations of splicing loci should be considered. To solve this problem, an
empirical method was used to directly combine two distant positions without
searching for all possibilities. This method combines two loci likely to result
from the same transcript using known gene annotation information (Trapnell
et al., 2010). However, extensive splice site mutations in cancer cells produce
many noncanonical splice sites that can not be joined because their gene anno-
tation is unknown (Jayasinghe et al., 2018). This noncanonical site, which can
not be assigned directly to a specific transcript, can increase the complexity of
transcriptome assembly and the possibility of assembly errors.
Therefore, there is a need to develop a new method for solving the above
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problems. The following sections describe the definition (method) and perfor-
mance (results) of our method.
Local analysis approach
As discussed in the previous section, transcript assembly in cancer is very diffi-
cult due to complex splicing patterns, noncanonical splice sites, and short-length
sequence reads. Therefore, a local analysis approach was devised to avoid tran-
scriptome assembly. In this scheme, all RNA-seq reads that support the splicing
event are locally separated and grouped, with each group corresponding to each
intron region (Figure 3.1). Spliced aligners such as RNA-STAR (Dobin et al.,
2013) align RNA reads with reference genome sequences and output mapped
positions on chromosomes.
Because RNA-seq is derived from mature mRNA transcripts, the spliced
region remains a gap in the resulting alignment. The aligner collects the spliced
gaps and organizes them into splice sites (ie, the ends of the intron). As a result,
the aligner lists the position of each splice site on the chromosome observed in a
given RNA-seq and the number of supporting reads. The list of splice junctions
extracted from the RNA-seq of each bulk tumor is the input data to construct
our model (Figure 3.1).
A local unit is then defined, called an intronic splicing unit (or splicing
unit), which is a collection of splicing events for each intron (Figure 3.1). In
this scheme, splice junctions sharing a common splice site are grouped into a
single unit. As in Figure 3.1, if three splice junctions are sharing a common
splice site upstream and three alternate sites downstream, a splicing unit S
consisting of A, B, and C can be defined. Where the input variable is defined
by the junction count of A, B and C (ie, CNTS=(5, 3, 2), Equation 3.1). The
probability distribution of S can be obtained by dividing the sum of the total
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Where CNTk(i) represents the number of RNA-seq reads that support i-th
alternative splice site in k-th splicing unit. Pk(i) is the fraction of RNA-seq
reads that support the i-th splice site of the k-th splicing unit. Nk is the total
number of alternative sites in k-th splicing unit.
3.3 A preliminary study
An experiment was conducted to test the effectiveness of the local analysis
approach. The key question is whether the ITH measured locally (ie, intron-level
ITH) is capable of reproducing ITH at the whole-transcript level. The TP53
gene was chosen because of its well-known implications for cancer progression
and its well-characterized isoform structure. TP53 has 15 isoforms and 12 exons
(O’Leary et al., 2015), which are complex enough to be used in experiments.
1,000 RNA-seq samples containing various combinations of 15 isoforms were
randomly generated. The RNA-seq simulation was performed using the well-
known NGS-seq generator WgSim (CMD: wgsim -e0 -r0 -R0 -X0 -S0 -A1 -d
500 -s 50) (MIT, 2011). The ITH of each sample was measured by the Shannon
entropy of the isoform usage profile, as in the study by Graf et al. (Graf and
Zavodszky, 2017). Where the value represents the uncertainty or heterogeneity




P (i)logP (i) (3.2)
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Figure 3.1: An illustration for intronic junction unit. An intronic splicing unit
is defined as a set of splicing events that share a common splicing site (ie, donor
or receiver) in the intronic domain. Each intronic splicing unit consists of an
isoform usage distribution of each sample in each locus. Here, the splice-site usage
distribution is calculated by the number of RNA-seq reads that support each
alternative splice-site (shown in red, purple, and green in the figure).
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Where P represents the TP53 isoform usage profile for each sample and N is
the total number of isoforms. Therefore, P (i) represents the ratio of isoform use
of i-th isoform of TP53 . The ITHtranscript represents the whole-transcript level
ITH determined by the predefined isoform usage profile, randomly assigned
to each sample. On the other hand, the local level ITH was measured using a
local splice-site usage distribution (Equation 3.1) extracted from 1,000 RNA-seq
samples. ITHintron represents the locally measured ITH defined as Equation
3.3.







Where Pk represents the isoform usage profile of the k-th splicing unit of TP53
gene and Nk is the number of isoforms in k-th splicing unit. Therefore, Pk(i)
represents the ratio of isoform usage of the i-th isoform in the k-th splicing unit.
Finally, L is the number of local splicing units in the TP53 gene. The locally
estimated ITH was shown to successfully reproduce the whole transcript level
ITH (Pearson r = 0.66, p = 1.63e-121) (Figure 3.2).
3.4 Methods
Normal tissues are also known to have heterogeneity in the use of isoforms
between cells (Shalek et al., 2013). To address this, the spliceomic ITH (ie, sITH)
was defined as the distance from the normal tissue sample to the bulk tumor
sample. By doing so, the model is expected to eliminate the innate heterogeneity
that exists in normal tissues, leaving only the perturbations that occur during
cancer progression.
The Jensen-Shannon Divergence (JSD) was chosen to measure the distance
between two data points. JSD is defined by averaging bidirectional Kullback-
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Figure 3.2: A scatter plot showing the correlation between the whole-transcript
level ITH and the locally estimated ITH in the TP53 gene. The X-axis represents
the whole-transcript level ITH (ie, ITHtranscript) and the Y-axis represents the
locally estimated ITH by averaging locally measured ITH (ie, ITHintron). Each
value is calculated from 1,000 simulated RNA-seq data.
Leibler Divergences (KLDs) from the introduced intermediate data points (Equa-
tion 3.4) (Lin, 1991; Joyce, 2011). Then JSD gets the symmetric property and
the metric value is limited from 0 to 1 (if you are using a base 2 log). JSD
has been used in bioinformatics studies for its symmetric property (Capra and
Singh, 2007; Azad and Li, 2012). We have defined input variables represent-
ing the distribution of isoform usage for each sample of each locus as a JSD
computable form (Equation 3.1).
JSD can be calculated for each intronic region (Equation 3.4). Because each
input variable is intended to reflect the use of the splice site at each intronic
region, the JSD between the two samples indicates how much the two samples
differ in their use of the splice site in that intronic region. This distance is scaled
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from 0 to 1. Where 0 means that the splice site usage pattern is the same and 1
is completely different. After calculating the JSD for each splicing unit, a single
ITH indicator representing the entire spliceome is calculated by averaging the

















JSD(Pk, Qk) represents the Jensen-Shannon divergence between the two distri-
butions Pk and Qk. Where Pk and Qk denote the splice-site usage distribution
of the k-th splicing unit in samples P and Q, respectively. Note that Pk and
Qk are defined in Equation 3.1. Mk represents the intermediate distribution
introduced between two distributions Pk and Qk designed to calculate bidi-
rectional Kullback-Leibler divergence (Equation 3.6). KLD(Pk‖Mk) represents
the Kullback-Leibler divergence of the distribution Pk from Mk. Two samples
can have different sets of splice sites. In that case, the pseudo-count is added
to the splice site, which is not found in one sample, where the pseudo-count








sITH(P,Q) represents the increased sITH of a sample P from the origin sample
Q to be compared. In the actual case, the target sample P corresponds to a
bulk tumor sample, and the origin sample Q corresponds to a normal sample. In
33
Figure 3.3: An illustration of how cancer progression affects splice-site usage
distribution and spliceomic ITH. Clonal heterogeneity increases as a result of
cancer progression, which changes the distribution of splice site use in bulk tumors.
The sITH is also designed to increase accordingly.
this case, sITH(P,Q) may be called sITH of sample P for convenience (Figure
3.3). L represents the total number of splicing units (usually 20∼30 thousands
units found in human cancer tissue). Here, the two samples to be compared
are pre-processed using the pseudo counting described above to have the same
number of splicing units for compatibility. Therefore, the i-th splicing unit of
samples P and Q represents the same intronic region.
The next section is a series of experiments to test whether sITH can function
as an ITH indicator and whether it is related to pathological, prognostic, and
molecular characteristics.
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3.5 Results & Discussion
Three experiments were performed to evaluate the proposed method using 1)
synthetic data, 2) xenograft tumor data, and 3) TCGA pan-cancer data.
3.5.1 Synthetic data
The first experiment was performed using synthetic data mixed with normal
breast tissue data with single breast cancer data. The purpose of this experiment
was to test how the sITH of the mixed sample changes as the mixing ratio
increases. The preparation method of the mixture is as follows.
112 Normal breast tissue RNA-seq data were collected from TCGA-BRCA
(Network et al., 2012). Then 39 single-cell breast cancer data were collected
from a study (SRA accession: SRP159204) (Zhu et al., 2018), where the 39 cells
were derived from different clones of a single breast tumor. Each RNA-seq data
was processed to obtain the splicing junctions, and the samples were combined
in various combinations. Our goal at this stage was to specify a predefined level
of ITH in each of the synthetic mixture samples. Initially, normal tissue data
were randomly selected from the pool of 112 normal tissues. Then, a certain
number of single-cell data were randomly selected, ranging from 1 ∼ 39. The
number of selected single-cells represents the ITH level of the mixture. Selected
single-cells were mixed into normal tissue at a rate of 1% per cell. For example,
if you set the predefined ITH level to 10, the 10 selected single-cell data will be
blended into normal tissue data at a 1% rate (10% total) for each cell. Here,
the mixing is performed by a weighted sum of the splicing junction counts for
each data (Equation 3.8).





Where i represents the assigned ITH level and j represents the j-th junction of
the mixture sample. MIX(i, j) represents the count of the j-th junction of the
resulted mixture sample with i ITH level. NT (j) represents the count of j-th
junction in the selected normal tissue sample. SC(l, j) represents the number
of j-th junction in the l-th selected single-cell cancer sample. Each of the 39
ITH levels was repeated 10 times with random sampling to avoid sampling
bias. For example, for ITH level 20, a normal tissue data and 20 single-cell data
are randomly selected 10 times each. Thus, a total of 390 mixture samples were
synthesized (10 iterations per 39 ITH levels). In conclusion, samples mixed with
more single-cells are expected to have a larger ITH by design.
sITH is measured from the origin sample to the target sample distance. In
this case, each mixture sample was a target sample, and the normal sample
corresponding to each mixture sample was the origin sample. Therefore, the
sITH of each mixture shows increased heterogeneity by mixing single-cells. The
resulting plot is depicted in Figure 3.4, showing a strong association between
the number of mixed single-cells and sITHs (Spearman: r=0.95, p=4.38e-198).
3.5.2 Xenograft tumor data
The main limitation of the previous synthetic data experiment is the lack of an
appropriate evolutionary model in the mixture generation. A xenograft tumor
data (SRA accession: SRP050242) was used to experiment with conditions that
reflect the actual clonal evolution (Chen et al., 2015). The xenograft mouse
model used in the experiments originally originated from the human breast
cancer cell line (MCF10A).
Cell lines were treated with HRAS transduction before transplantation
to enhance malignancy. After the single-cell origin derived from MCF10A-
HRAS was transplanted into immunocompromised mice, the xenograft tissues
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Figure 3.4: A Boxplot to show the association between the number of synthesized
single-cells and the sITH of synthesized data. The X-axis represents the number
of mixed single-cells (1∼39). The Y-axis represents the sITH of the sample mixed
with the number of single-cells specified on the X-axis.
were cultured until the tumor had completely progressed and metastasized.
DNA and RNA samples were collected at various points during the process.
Thus, the trends in ITH values measured by two different data types (genome
and spliceome) can be compared as the tumor grows. A total of 10 samples
were collected while culturing xenograft tissue. They collected two samples for
metastatic tissue and one sample for each of the eight time-points. For each
sample, sITH was calculated from the normal breast tissue samples provided
by TCGA-BRCA (Network et al., 2012). Ten randomly selected samples are
assigned to each xenograft sample to avoid sampling bias. The sITH of each
xenograft sample is then iteratively calculated for each of the 10 normal sam-
ples.
The goal at this stage was to test how the sITH of a tumor changes as cancer
progresses and the clonal substructure expands. Initially, it was tested how sITH
changes over time. As shown in Figure 3.5-(a), sITH has a positive correlation
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Figure 3.5: Two boxplots of how the xenograft time-point and estimated sub-
clone numbers are associated with sITH. a) The X-axis represents when each
xenograft tumor sample was collected. The Y-axis represents the sITH for each
sample (including repeated measurements for 10 normal tissues randomly selected
for each tumor sample). b) Same as a) except that the X-axis represents the num-
ber of subclones estimated by PyClone.
with the time point (Spearman: r=0.88, p=1.39e-33), which means that sITH
increases as the cancer progresses. Next, it was tested how sITH changes as the
number of subclones increases. The study by Chen et al. (Chen et al., 2015) used
PyClone to give the estimated number of subclones in each sample, and these
values were compared to sITH. As shown in Figure 3.5-(b), sITH is strongly
correlated with the number of subclones (Spearman: r=0.86, p=6.09e-30), which
means that sITH increases as the clonal substructure expands.
3.5.3 TCGA pan-cancer data
There are more problems to consider in clinical cases. For example, unlike
xenograft samples that share a common ancestral cell, samples from actual
cancer patients originated from diverse populations. This heterogeneity between
patients due to various genetic backgrounds can be a confounding factor that
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might mask the actual ITH. It is also unclear whether the tissue of origin could
affect the outcome because only breast cancer tissues were tested in previous
experiments. Thus, a comprehensive pan-cancer level experiment was needed to
test whether sITH could overcome potential problems and demonstrate clinical
significance.
For this purpose, the TCGA pan-cancer dataset was used (Weinstein et al.,
2013). The TCGA pan-cancer dataset is a cancer cohort collective that includes
28 cohorts and 9,274 bulk tumor RNA-seq samples (Table 3.1). Corresponding
normal tissues are needed to calculate the sITH of bulk tumors, 8 of the 28
groups are excluded because there is no normal tissue. This means that 984
samples were excluded. Overall there are 8,290 available primary tumor samples
of 20 types of cancer (Table 3.1). The sITH of each bulk tumor was calculated
by processing 8,290 RNA-seq data before experimenting. The sITH of bulk
tumor samples in each cohort is calculated using the corresponding normal
tissue samples. For example, the TCGA breast cancer cohort (BRCA) has 1,093
primary bulk tumor RNA-seq samples and 112 normal tissue RNA-seq samples.
In this case, the sITH of each bulk tumor sample was calculated by averaging
the calculated sITHs for each of the 112 normal tissue samples.
The measured sITH values of each bulk tumor sample were compared with
clinical features such as genomic ITH (gITH), cancer stage, survival outcome
and PAM50 subtype. The following sections describe the comparison procedure
and the results.
Comparison with gITH
The gITH used in the experiment is the result of ABSOLUTE (Carter et al.,
2012). A study by TCGA provides gITH values for pan-cancer dataset (Wein-
stein et al., 2013). Of the 8,290 samples with sITH values, 7,594 samples had
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DISEASE NT PT sITH gITH STAGE SURVIVAL PAM50
BRCA 112 1,093 1,086 1,013 995 322 480
KIPAN 129 889 889 659 632 287 0
GBMLGG 5 669 669 644 0 275 0
STES 46 599 599 558 522 232 0
HNSC 44 520 520 485 422 238 0
LUAD 59 515 515 489 487 210 0
LUSC 51 501 501 465 464 245 0
THCA 59 501 501 446 444 97 0
PRAD 52 497 497 469 0 87 0
BLCA 19 408 408 398 396 211 0
COADREAD 51 379 379 351 338 109 0
LIHC 50 371 371 354 333 155 0
CESC 3 304 304 291 0 99 0
SARC 2 259 259 242 0 125 0
PCPG 3 179 179 160 0 31 0
PAAD 4 178 178 158 156 91 0
UCEC 24 176 176 170 0 45 0
THYM 2 120 120 103 0 36 0
SKCM 1 103 103 103 99 29 0
CHOL 9 36 36 36 36 19 0
OV 0 303 0 0 0 0 0
LAML 0 173 0 0 0 0 0
TGCT 0 150 0 0 0 0 0
MESO 0 87 0 0 0 0 0
UVM 0 80 0 0 0 0 0
ACC 0 79 0 0 0 0 0
UCS 0 57 0 0 0 0 0
DLBC 0 48 0 0 0 0 0
SUM 725(20) 9,274(28) 8,290(20) 7,594(20) 5,324(13) 2,943(20) 480(1)
Table 3.1: A table for input feature evaluation results.
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matched gITH values, and the remaining 696 samples were not provided with
gITH values and were excluded from the comparison (Table 3.1).
The Spearman correlation test showed a strong correlation between sITH
and gITH (r=0.24, p=6.92e-100). To summarize the vast quantities of results,
a percentile boxplot was prepared (Figure 3.6). Where each box contains 10%
of the sample in ascending order of gITH. For example, the first box in Figure
3.6 contains samples with gITH rank between 0 and 10%, and the second box
contains 10% to 20% samples. The binned representation of Figure 3.6 is used
only for visualization, and the actual correlation test is performed by directly
comparing the sITH and gITH values of each sample.
gITH is the current golden standard for ITH levels in bulk tumors. Thus, it
was used as a reference standard for sITH in all of the following comparisons
Figure 3.6: A boxplot representing the relationship between gITH and sITH.
The X-axis consists of 10 bins that evenly divide the entire sample. Each bin
corresponds to a 10 percent scale percentile, ordered by the gITH value of each
sample. The result indicates a significant correlation between gITH and sITH.
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Comparison with cancer stage
The cancer stage is a well-known indicator of cancer progression, which is deter-
mined based on pathological observations of cancer tissues such as size, location,
the extent of invasion, and extent of spread. The level of ITH is generally related
to the progression of cancer.
Of the 7,594 samples containing both sITH and gITH, 5,324 samples also
have cancer stage information (Table 3.1). Figure 3.7 summarizes the correlation
between sITH, gITH and cancer stage in each sample. Both ITHs showed a
significant correlation with cancer stage, but sITH showed better association
(gITH: r=0.11, p=8.11e-17, sITH: r=0.24, p=2.43e-68). The result means that
the samples with higher cancer stages have a larger sITH value.
Association with survival outcome
Overall survival represents the survival time after treatment, which is the sur-
gical resection of the tumor in this context. The level of ITH in the tumor is
associated with the degree of malignancy of cancer, which in turn affects the
mortality rate of cancer patients (Morris et al., 2016). Therefore, the relation-
ship between sITH, gITH and the survival outcome of each sample was tested.
The Cox proportional hazards (Coxph) model was prepared to test 7,594
samples with both sITH and gITH (table 3.1). The Cox regression model is
designed to quantify the effect of sITH and gITH on overall survival, where
the magnitude of the association is expressed as a p-value. The ”CoxPHFit-
ter” function used in the experiment is included in the Python library lifelines
(0.21.0). The results of the analysis are summarized in Table 3.2.The results
show that sITH is significantly associated with overall survival (HR=1.85e+23,
p =1.04e-64). It is better than gITH (HR=3.8, p=1.95e-28).
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Figure 3.7: A boxplot showing the association of sITH, gITH and cancer stages
in each sample. a) The X-axis represents the cancer stage of each sample (1 to 4
stages). The y-axis represents the sITH value of each sample. b) Same as a), but in
this case, the Y-axis represents the gITH value of each sample. The results show
that both sITH and gITH have a significant correlation with the cancer stage, and
the significance is greater in sITH. The sITH and gITH values were standardized
by dividing the maximum value between samples so that the distribution of the
data is easily understood.
An additional analysis was prepared to help visual understanding. Initially,
7,594 samples were classified into six groups with different survival outcomes.
The first five groups were classified by the time of death. For example, the
first group contains samples that died in the first year after treatment, and the
second group contains samples that died in the second year. The sixth group
includes samples reported to be alive for more than 5 years, where the 5-year
threshold is based on criteria commonly used to determine cancer remission. As
a result, 2,943 samples were classified into six survival groups and the remainder
were excluded because they could not be classified into six groups because of
the short follow-up period (Table 3.1).
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coef exp(coef) se(coef) z p value lower 0.95 upper 0.95
sITH 53.57 1.85E+23 3.15 16.99 1.04E-64 47.39 59.76
gITH 1.34 3.80 0.12 11.06 1.95E-28 1.1 1.57
Table 3.2: A table for Cox proportional hazards analysis results.
Figure 3.8 summarizes the association between sITH, gITH and the sur-
vival group of each sample. Both gITH and sITH were significantly corre-
lated with survival groups, whereas sITH showed better association (gITH: r=-
0.20, p=1.75e-27, sITH: r=-0.27, p=6.44e-51). The result indicates that sample
groups having higher lethality have a tendency to have greater sITH. The sam-
ple information for each sample group is summarized in Table 3.1.
Association with PAM50 subtype
One of the most studied cancer types in terms of the molecular level is breast
cancer, and breast cancer has a well-known molecular subtyping system, PAM50
((Parker et al., 2009)). PAM50 classifies breast tumors into four types: Luminal
A, Luminal B, Her2-enriched, and Basal. The order here indicates the degree of
malignancy. The associations of sITH, gITH, and PAM50 subtypes were tested.
Of the 1,013 breast cancer samples available for both sITH and gITH, 480
samples have PAM50 subtype information. Both ITHs showed a significant cor-
relation with the PAM50 subtype (Figure 3.9), while sITH showed a better
correlation (gITH: r=0.36, p=2.91e-16, sITH: r=0.61 , p= 1.11e-48). The ex-
periment results indicate that groups of samples that are expected to be more
malignant by molecular subtypes tend to have a higher sITH.
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Figure 3.8: A boxplot indicating the association between sITH, gITH and the
survival outcome of each sample. a) The X-axis represents a sample population
that is classified into the overall survival results of each sample (1YDEAD ∼
5Y DEAD, and 5Y SURVIVAL). For example, the 1Y DEAD group represents
a sample that dies within one year of surgery. Similarly, 2Y DEAD corresponds
to samples that died within two years of treatment. The remaining groups are
defined accordingly. Finally, the 5Y SURVIVAL group represents the samples that
survived 5 years after surgery. The Y-axis represents the sITH value of each
sample. b) Same as a). However, this time, the Y-axis represents the gITH value of
each sample. Both sITH and gITH showed a significant correlation with survival,
but sITH showed a better correlation than gITH. The sITH and gITH values
were standardized by dividing the maximum value between samples so that the
distribution of the data was easily understood.
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Figure 3.9: A boxplot indicating the association between sITH, gITH and the
PAM50 subtype of each breast cancer sample. a) The X-axis represents the PAM50
subtype of each sample sorted by the known malignancy order of each subtype.
The Y-axis represents the sITH value of each sample. b) Same as a). However,
this time, the Y-axis represents the gITH value of each sample. Both sITH and
gITH showed a significant correlation with PAM50 subtype, but sITH showed a
better correlation than gITH. The sITH and gITH values were standardized by
dividing the maximum value between samples so that the distribution of the data
was easily understood.
3.6 Conclusion
Despite studies that show intercellular differences at the spliceome level(Shalek
et al., 2013; Wan and Larson, 2018), the clinical effect of sITH has not been
studied sufficiently because there is no sITH model. SpliceHetero is a sITH
model based on local analysis approach that avoids transcriptome assembly
which is not easy in cancer RNA-seq. The proposed model was extensively
tested for its performance using synthetic data, xenograft tumor data, and
TCGA pan-cancer data. As a result, sITH has shown a strong association with
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cancer progression and clonal heterogeneity as well as clinically relevant features
such as cancer progression, survival outcome, and PAM50 subtype. Also, the
distribution of sITH values within each sample group appears more strict than
gITH (Figure 3.7, Figure 3.8 and Figure 3.9). That means sITH is a more
consistent indicator than gITH.
The proposed model can help to develop diagnostic and prognostic tools
by providing a tool to understand the inherent heterogeneity of cancerous
spliceome. The whole process is implemented as a software package and is
available free at http://biohealth.snu.ac.kr/software/SpliceHetero. It was im-




Tumor2Vec: A supervised learning
algorithm for extracting
subnetwork representations of
cancer RNA-seq data using
protein interaction networks
4.1 Related works
Precision cancer medicine is a new form of medical practice that provides opti-
mal treatment for each cancer patient by considering the genetic and molecular
background as well as clinical history and pathology (Figure 4.1). The basic
idea is that medical decisions for each patient can be made by considering the
treatment records of previous patients with similar molecular profiles. Thus,
one of the major challenges of precision cancer medicine is defining a patient
subspace, where the patient-patient distance is defined based on the molecular
profile.
RNA-seq is one of the most promising techniques for extracting whole-
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Figure 4.1: An illustration for describing precision cancer medicine.
transcriptome profiles of cancer patients. However, the high-dimensional nature
of RNA-seq data (more than 20,000 genes to consider) makes it difficult to define
the optimal feature representation that can characterize each patient (Figure
4.2) (McGettigan, 2013; Shen et al., 2016). Because the cost of producing RNA-
seq data is still significant, a solution is needed to reduce the dimensionality of
the data. There are two main approaches to dealing with this problem.
1. The unsupervised dimension reduction approach mathematically elim-
inates data redundancy and provides component values that represent
each reduced embedding dimension as feature values.
2. The network-based transcriptome analysis approach removes the redun-
dancy of data by grouping genes into subnetwork modules using pro-
tein interaction networks and then integrating biologically interdependent
genes into a single feature.
The unsupervised dimension reduction approach has been used to reduce
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Figure 4.2: An illustration for describing the high-dimensionality issue in RNA-
seq.
the data dimension of RNA-seq and has shown particularly good performance
when visualizing a collection of data (Treutlein et al., 2014; Wang and Gu,
2018). One limitation of this approach is that it does not provide a biological
interpretation of the results. Researchers have to make their own interpreta-
tions, and sometimes the same data can lead to different conclusions depending
on the interpreter. The network-based transcriptome analysis approach has the
advantage that it provides intuitively interpretable subnetwork level features.
Subnetworks defined by protein interaction networks have been associated
with various biological phenotypes using a systems biology approach. Most cur-
rent approaches, however, rely heavily on feature engineering, which requires
domain expertise and manual curation (Yu et al., 2013; Xiong et al., 2017; Fan
et al., 2018). Two approaches have recently been introduced to extract subnet-
work features associated with specific biological phenotypes in an automated
manner.
1. Yuan et al. (Yuan et al., 2017) introduced a greedy search algorithm
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to find subnetwork features in a protein interaction network (PIN). They
defined subnetwork features starting from one gene to finding locally max-
imized boundaries in terms of defined perturbation scores.
2. Lin et al. (Lin et al., 2017) used a neural network model to find network-
based feature representations. They used knowledge bases containing gene
regulation structures such as TF networks and PINs to build selectively
connected neural network architectures. The internal weights, which are
calculated as a result after training the neural network, are considered to
be network-level features.
4.2 Motivation
The approach of Yuan et al. (Yuan et al., 2017) considered each local subnet-
work as an independent variable in assessing the impact on the corresponding
biological phenotype and did not consider their interactions. Therefore, this ap-
proach has limitations in dealing with complex diseases such as cancer, because,
in cancer, two or more intracellular processes interact to produce a cancer phe-
notype (Prahallad and Bernards, 2016). The approach of Lin et al. (Lin et al.,
2017) is free from this problem because it considers interactions between local
subnetworks by using a fully connected neural network architecture. However,
despite its high performance, this model has the limitation that it is not easy
to interpret its data representation. Therefore, there is a need for a supervised




Extraction of local subnetworks
Tumor2Vec uses the graph embedding technique applied to the PIN to deter-
mine the globally well-tuned local subnetwork community. Each community is
then considered a feature representation of the input data. The process is as
follows.
• First, protein interaction information is extracted from a well-organized
PIN database STRING. (Szklarczyk et al., 2018). The PIN graph is then
constructed from that information.
• The PIN graph is then processed by the graph embedding algorithm
DeepWalk (Figure 4.3) (Perozzi et al., 2014). Here, the graph embed-
ding algorithm is performed to find globally well-tuned local subnetwork
communities. Through graph embedding, each gene is transformed into
an embedding space where the intergenic distance represents the random
walk probability distribution of the original PIN graph (Perozzi et al.,
2014).
• K-means clustering is applied to all genes to find clusters, where the inter-
genic distance is measured using the coordinates in the embedding space.
Thus, the resulting clusters represent the local connection of the origi-
nal PIN graph (Perozzi et al., 2014). These clusters are considered local
subnetwork features (Figure 4.4).
Training of the kernel function
Recent supervised learning methods that rely on network-based features typi-
cally use explicit models (Conte et al., 2013) that learn functions that map input
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Figure 4.3: An illustration of the graph embedding process (Perozzi et al., 2014).
Figure 4.4: An illustration of the subnetwork clustering process.
variables to sample labels. For example, the approach of Lin et al. (Lin et al.,
2017) uses an explicit model in which a protein interaction network structure
is embedded within a neural network architecture. This approach is useful for
improving the performance of the backend prediction model, but it is limited
in that the resulting data representation does not provide a biological interpre-
tation. In this study, the implicit model (Conte et al., 2013) was used. In the
implicit model, the kernel function is trained to define the distance between
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samples, and the kernel’s objective function is specified so that the distance be-
tween samples can represent the label difference between samples. The training
process is as follows (Figure 4.5).
• First, input instances for training the kernel function are collected by a
pairwise sample comparison, and each pair of samples is considered an
instance.
• For each instance, distances are measured for each cluster. Since each
cluster is considered as a vector of the expression values of the included
genes, the distance means the distance between vectors.
• Sample label differences (ie, equality: 0 and other: 1) are assigned to each
sample pair, which is used as a target variable when training the kernel
function.
• The learning algorithm used in the kernel is a non-negative least squares
(NNLS) regression, which is implemented in the Python library scipy op-
timize nnls (Lawson and Hanson, 1995; Bro and De Jong, 1997). The
NNLS problem is to find a vector d (K) that minimizes the following ex-
pression (4.1) for given Z (N ×K) and x (N ×1). Here the d is the vector
of weights that corresponds to K clusters and Z is the inter-sample dis-
tances at each N instances K clusters and x represents the label difference
at each sample pair instances.
∥∥x− Zd2∥∥ (4.1)
If dm is a m-th element of d and dm > 0, then dm, which is the weight of
the m-th cluster, represents the importance of that subnetwork commu-
nity. Where 0 means that the difference in gene expression in the cluster
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does not affect the label difference, and a larger value indicates greater
significance.
• After training the kernel, the distance between samples can be measured
as a weighted sum of the distance of each cluster of two samples.
Figure 4.5: An illustration showing the kernel function training process.
Construction of autoencoder for sample embedding calculation
Because the trained kernel functions provide only the distance between samples,
an additional step is needed to generate reduced embedding for each RNA-seq
sample. An autoencoder model was devised to calculate the sample embedding.
The process is as follows (Figure 4.6).
• First, the distance between all training samples is measured using the
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trained kernel. Each sample can then be defined as a vector of distances
for all other training samples.
• An autoencoder model (Bengio et al., 2009) is created that uses the vec-
tors of distances as input values and has the neural network architecture
specified by the user.
• After training the neural network, the embedding of each sample can
be calculated by taking the value of the bottleneck layer after forward
propagation.
• When data that has not yet been observed is input, the sample is first
measured for all training samples and the vector of distances is entered
into the autoencoder to generate the embedding.
Figure 4.6: An illustration showing the autoencoder training process process.
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4.4 Results & Discussion
4.4.1 Lymph node metastasis in early oral cancer
Tumor2Vec was tested in a cancer study to predict lymph node metastasis in
early oral cancer. The TCGA-HNSC dataset was used (Network et al., 2015).
The data configuration is as follows.
Materials
Of the 566 RNA-seq samples from TCGA-HNSC, only early oral carcinoma
samples with lymph node metastasis information were used. That is, tumor
samples classified as the oral tongue, alveolar ridge, hard plate, floor of mouth,
buccal mucosa, and oral cavity were used. The criterion for the early disease
is the pathological T stage within T1 ∼ T2. In conclusion, there are 60 early
oral cancer samples available for lymph node metastasis, 28 of which are pos-
itive for lymph node metastasis and 32 negatives. The PIN for subnetwork
extraction was extracted from the STRING protein-protein interaction (PPI)
network database (Szklarczyk et al., 2014). Interaction edges are filtered with
a combined score of 900 to eliminate low confidence interactions.
Results of analysis
The purpose of this analysis is to identify subnetwork level expression patterns
(ie, features) that affect lymph node metastasis in early oral cancer. The pro-
cessing of data is as follows.
• Gene expression profiles of 60 oral cancer samples generated by TCGA
were collected, which were measured by RSEM(Li and Dewey, 2011).
These cancer samples were normalized using 13 normal oral tissue samples
collected from TCGA. In this case, Z-normalization was used.
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• Since the available samples are relatively small, only 4,307 genes selected
as cancer hallmark gene set in MSigDB were used (Subramanian et al.,
2005). Of these, 865 genes are excluded because they are not PPI related
to other genes on the STRING PIN (based on edge score >900 cut). As
a result, 3,442 genes were used.
• The figure 4.7 is the result of using 91 clusters, and the optimal number
of clusters was determined within the range of 10 ∼ 200 by 5-fold cross-
validation.
• After the kernel was trained by this configuration, its weight indicates the
functional significance of each subnetwork and is displayed as a heatmap,
as shown in Figure 4.7-b. Then an autoencoder was created, in which
sample embeddings were calculated in two dimensions for visualization
and the results are shown in Figure 4.7-a.
• A simple classification model called Nearest Centroid classifier (Tibshirani
et al., 2002) was created to test how well the generated two-dimensional
sample embeddings distinguish sample labels. The results were 78.3% of
the training accuracy and 73.3% of the test accuracy.
Interpretation of subnetwork features
Feature importance of each cluster (ie, subnetwork feature) can be extracted
from the trained kernel. The clusters with the top three high scores are listed
in the table 4.1. The KEGG TOP3 column contains the geneset enrichment
results from Enrichr (Kuleshov et al., 2016), which lists the top three enrichment
score pathways. The genes in each cluster are closely linked according to the
STRING PPI (Figure 4.8, 4.9, 4.10). This indicates that graph embedding based
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Figure 4.7: Two plots for the results of early oral cancer analysis.
clustering captures the original PIN structure well.
Cluster 1: Subnetwork to regulate leukocyte cell adhesion
Cluster 1 contains genes associated with the tight junction, cell adhesion, and
leukocyte migration known to be closely associated with lymph node metastasis
in oral cancer (van den Brand et al., 2010; Kudo et al., 2004,?).
Figure 4.8: A plot showing the STRING PPI interaction between genes in Clus-
ter 1.
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Cluster Kernel Weight Size KEGG TOP3
1 0.233007846 16
Tight junction(10)
Cell adhesion molecules (CAMs) (9)
Leukocyte transendothelial migration(9)
2 0.185200417 5
Arginine and proline metabolism(3)
Glycine, serine and threonine metabolism(3)
Tight junction(2)
3 0.15502751 71
Th17 cell differentiation (18)
Inflammatory bowel disease (IBD) (16)
Cytokine-cytokine receptor interaction (46)
Table 4.1: A table of KEGG enrichment results for Top 3 important subnetwork
features.
Figure 4.9: A plot showing the STRING PPI interaction between genes in Clus-
ter 2.
4.5 Conclusion
Current dimensional reduction techniques have limitations in that they do not
provide a biological interpretation. Tumor2Vec is a machine learning model de-
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Figure 4.10: A plot showing the STRING PPI interaction between genes in
Cluster 3.
veloped to extract subnetwork features that best describe biological phenotype
while considering interactions among subnetworks in the training phase. It was
tested to identify subnetwork features associated with lymph node metastasis
with early oral cancer data. It was able to reproduce clinical knowledge and




Due to the complex regulatory system, the transcriptome is essentially a mix-
ture containing various transcriptomic variations. This often makes it difficult
to see an overall picture of transcriptomic events that regulate biological pheno-
types. The goal of my doctoral study was to eliminate the barriers to decoding
and utilizing RNA-seq to uncover the landscape of key transcriptomic events.
Three key challenges have been addressed using machine learning techniques.
Each challenge is summarized as follows:
1. false-positives in RNA editing calls
2. Absence of a model for measuring spliceomic intratumor heterogeneity
considering complex cancer spliceome
3. Lack of biological interpretation of dimension reduction techniques using
gene expression
In the first study, RDDpred, a condition-specific machine learning model
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for filtering false-positive RNA editing calls in RNA-seq data, was developed.
There have been limitations to existing methods such as non-machine learning
methods lacking generality and machine learning methods requiring extensive
proactive experimental validation. RDDpred is a machine learning technique
that overcomes these limitations. It uses prior knowledge bases to extract train-
ing samples directly from the input data and then generates machine learning
predictors specific to the input conditions. RDDpred was tested using the re-
sults of two previous studies and showed good results by significantly reducing
the false-positive rate while reproducing most of the residues reported in both
studies.
In the second study, SpliceHetero, an information-theoretic approach for
measuring spliceomic intratumor heterogeneity from bulk tumor RNA-seq data,
was developed to solve technical problems caused by complex cancer spliceome.
Despite studies that show intercellular differences at the spliceome level, the
clinical effect of sITH has not been studied sufficiently because there is no
sITH model. SpliceHetero is a sITH model based on local analysis approach
that avoids transcriptome assembly which is not easy in cancer RNA-seq. The
proposed model was extensively tested for its performance using synthetic data,
xenograft tumor data, and TCGA pan-cancer data. As a result, sITH has shown
a strong association with cancer progression and clonal heterogeneity as well
as clinically relevant features such as cancer progression, survival outcome, and
PAM50 subtype.
In the last study, Tumor2Vec, a supervised learning algorithm for extracting
subnetwork representations of cancer RNA-seq data using protein interaction
networks, was developed. Current dimensional reduction techniques have limi-
tations in that they do not provide a biological interpretation. Tumor2Vec is a
machine learning model developed to extract subnetwork features that best de-
63
scribe biological phenotype while considering interactions among subnetworks
in the training phase. It was tested to identify subnetwork features associated
with lymph node metastasis with early oral cancer data. It was able to repro-
duce clinical knowledge and identify potential subnetwork markers.
In conclusion, my doctoral study challenged three major barriers in decoding
and utilizing RNA-seq using machine learning techniques. It contributed to the
field of bioinformatics by providing solutions to key challenges and opened the
way to integrate three transcriptomic domains (ie, RNA editing, alternative
splicing, and gene expression) to see an overall picture of transcriptomic events.
64
Bibliography
Azad, R. K. and Li, J. (2012). Interpreting genomic data via entropic dissection.
Nucleic acids research, 41(1), e23–e23.
Bahn, J. H., Lee, J.-H., Li, G., Greer, C., Peng, G., and Xiao, X. (2012). Accu-
rate identification of a-to-i rna editing in human by transcriptome sequencing.
Genome research, 22, 142–150.
Bass, B., Hundley, H., Li, J. B., Peng, Z., Pickrell, J., Xiao, X. G., and Yang,
L. (2012). The difficult calls in rna editing. Nature biotechnology , 30(12),
1207.
Bengio, Y. et al. (2009). Learning deep architectures for ai. Foundations and
trends® in Machine Learning , 2(1), 1–127.
Boland, C. R. and Goel, A. (2005). Somatic evolution of cancer cells. In
Seminars in cancer biology , volume 15, pages 436–450. Elsevier.
Bro, R. and De Jong, S. (1997). A fast non-negativity-constrained least squares
algorithm. Journal of Chemometrics: A Journal of the Chemometrics Soci-
ety , 11(5), 393–401.
65
Capra, J. A. and Singh, M. (2007). Predicting functionally important residues
from sequence conservation. Bioinformatics , 23(15), 1875–1882.
Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T.,
Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012). Ab-
solute quantification of somatic dna alterations in human cancer. Nature
biotechnology , 30(5), 413.
Chen, H., Lin, F., Xing, K., and He, X. (2015). The reverse evolution from mul-
ticellularity to unicellularity during carcinogenesis. Nature communications ,
6, 6367.
Chiu, Y.-L., Soros, V. B., Kreisberg, J. F., Stopak, K., Yonemoto, W., and
Greene, W. C. (2010). Cellular apobec3g restricts hiv-1 infection in resting
cd4+ t cells. Nature, 466, 276–276.
Cichocki, A. and Phan, A.-H. (2009). Fast local algorithms for large scale non-
negative matrix and tensor factorizations. IEICE transactions on fundamen-
tals of electronics, communications and computer sciences , 92(3), 708–721.
Climente-González, H., Porta-Pardo, E., Godzik, A., and Eyras, E. (2017). The
functional impact of alternative splicing in cancer. Cell reports , 20(9), 2215–
2226.
Conte, D., Ramel, J.-Y., Sidère, N., Luqman, M. M., Gaüzère, B., Gibert, J.,
Brun, L., and Vento, M. (2013). A comparison of explicit and implicit graph
embedding methods for pattern recognition. In International Workshop on
Graph-Based Representations in Pattern Recognition, pages 81–90. Springer.
Degner, J. F., Marioni, J. C., Pai, A. A., Pickrell, J. K., Nkadori, E., Gilad, Y.,
66
and Pritchard, J. K. (2009). Effect of read-mapping biases on detecting allele-
specific expression from rna-sequencing data. Bioinformatics , 25, 3207–3212.
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut,
P., Chaisson, M., and Gingeras, T. R. (2013). Star: ultrafast universal rna-seq
aligner. Bioinformatics , 29, 15–21.
Dvinge, H. and Bradley, R. K. (2015). Widespread intron retention diversifies
most cancer transcriptomes. Genome medicine, 7(1), 45.
Engström, P. G., Steijger, T., Sipos, B., Grant, G. R., Kahles, A., Alioto, T.,
Behr, J., Bertone, P., Bohnert, R., Campagna, D., et al. (2013). Systematic
evaluation of spliced alignment programs for rna-seq data. Nature methods,
10(12), 1185.
Eswaran, J., Horvath, A., Godbole, S., Reddy, S. D., Mudvari, P., Ohshiro, K.,
Cyanam, D., Nair, S., Fuqua, S. A., Polyak, K., et al. (2013). Rna sequencing
of cancer reveals novel splicing alterations. Scientific reports , 3, 1689.
Fan, P., Lin, Q.-H., Guo, Y., Zhao, L.-L., Ning, H., Liu, M.-Y., and Wei, D.-Q.
(2018). The ppi network analysis of mrna expression profile of uterus from
primary dysmenorrheal rats. Scientific reports, 8(1), 351.
Galeano, F., Rossetti, C., Tomaselli, S., Cifaldi, L., Lezzerini, M., Pezzullo, M.,
Boldrini, R., Massimi, L., Di Rocco, C., Locatelli, F., et al. (2013). Adar2-
editing activity inhibits glioblastoma growth through the modulation of the
cdc14b/skp2/p21/p27 axis. Oncogene, 32, 998–1009.
Graf, J. F. and Zavodszky, M. I. (2017). Characterizing the heterogeneity of
tumor tissues from spatially resolved molecular measures. PloS one, 12(11),
e0188878.
67
Greaves, M. and Maley, C. C. (2012). Clonal evolution in cancer. Nature,
481(7381), 306.
Haas, B. J. and Zody, M. C. (2010). Advancing rna-seq analysis. Nature biotech-
nology , 28(5), 421.
Hall, M., Frank, E., Holmes, G., Pfahringer, B., Reutemann, P., and Witten,
I. H. (2009). The weka data mining software: an update. ACM SIGKDD
explorations newsletter , 11, 10–18.
Heap, G. A., Yang, J. H., Downes, K., Healy, B. C., Hunt, K. A., Bockett,
N., Franke, L., Dubois, P. C., Mein, C. A., Dobson, R. J., et al. (2010).
Genome-wide analysis of allelic expression imbalance in human primary cells
by high-throughput transcriptome resequencing. Human molecular genetics,
19, 122–134.
Hoffman, M., Bach, F. R., and Blei, D. M. (2010). Online learning for latent
dirichlet allocation. In advances in neural information processing systems,
pages 856–864.
Jardim-Perassi, B. V., Alexandre, P. A., Sonehara, N. M., de Paula-Junior, R.,
Júnior, O. R., Fukumasu, H., Chammas, R., Coutinho, L. L., and de Cam-
pos Zuccari, D. A. P. (2019). Rna-seq transcriptome analysis shows anti-
tumor actions of melatonin in a breast cancer xenograft model. Scientific
reports, 9(1), 966.
Jayasinghe, R. G., Cao, S., Gao, Q., Wendl, M. C., Vo, N. S., Reynolds, S. M.,
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Liu, Y., Gonzàlez-Porta, M., Santos, S., Brazma, A., Marioni, J. C., Aebersold,
R., Venkitaraman, A. R., and Wickramasinghe, V. O. (2017). Impact of
alternative splicing on the human proteome. Cell reports, 20(5), 1229–1241.
70
Maaten, L. v. d. and Hinton, G. (2008). Visualizing data using t-sne. Journal
of machine learning research, 9(Nov), 2579–2605.
Marusyk, A. and Polyak, K. (2010). Tumor heterogeneity: causes and conse-
quences. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer , 1805(1),
105–117.
Mazor, T., Pankov, A., Song, J. S., and Costello, J. F. (2016). Intratumoral
heterogeneity of the epigenome. Cancer cell , 29(4), 440–451.
McGettigan, P. A. (2013). Transcriptomics in the rna-seq era. Current opinion
in chemical biology , 17(1), 4–11.
McGranahan, N. and Swanton, C. (2017). Clonal heterogeneity and tumor
evolution: past, present, and the future. Cell , 168(4), 613–628.
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernyt-
sky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010).
The genome analysis toolkit: a mapreduce framework for analyzing next-
generation dna sequencing data. Genome research, 20, 1297–1303.
Minka, T. P. (2001). Automatic choice of dimensionality for pca. In Advances
in neural information processing systems, pages 598–604.
MIT (2011). Wgsim.
Mo, F., Wyatt, A. W., Sun, Y., Brahmbhatt, S., McConeghy, B. J., Wu, C.,
Wang, Y., Gleave, M. E., Volik, S. V., and Collins, C. C. (2014). Systematic
identification and characterization of rna editing in prostate tumors. PloS
one, 9(7), e101431.
Morris, L. G., Riaz, N., Desrichard, A., Şenbabaoğlu, Y., Hakimi, A. A.,
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초록
진핵 세포 시스템에서는 mRNA 분자가 전사된 이후 완전히 처리되어 단백질로
번역될때까지여러단계의전사후조절과정을거치게된다.전사후조절과정은
RNA 편집, 선택적 접합, 선택적 아데닐화 등을 포함한다. 즉 어느 한 시점에서 전
사체를 들여다보면 그 내부는 다양한 중간체들의 혼합물로 구성되어 있는 것이다.
이러한 복잡한 조절 시스템 때문에 전사체를 전체적인 수준에서 이해하기가 쉽지
않다. 본 학위 연구는 RNA 시퀀싱 데이터를 해독하고 활용하기 위한 기계학습 기
법들에 대한 연구이며 RNA 편집, 선택적 접합 및 유전자 발현의 관점에서 수행된
세 가지 연구로 구성된다.
RNA 편집은 ADAR(A=>I) 과 APOBEC(C=>U) 두 가지 효소에 의해 촉매
되는 전사 후 RNA 서열 조절 기작이다. RNA 편집은 단백질 활성도, 선택적 접합
및 miRNA 표적 조절 등 다양한 세포 기작을 제어하는 것으로 알려진 중요한 새
포 내 조절 시스템이다. RNA 시퀀싱을 이용해 RNA 편집 현상을 검출하는 것은
RNA 편집 현상의 생물학적 기능을 이해하는 데에 매우 중요하다. 문제는 이 과
정에서 상당한 양의 위양성이 발생한다는 점이다. 샘플당 수만 개 이상 발생하는
RNA 편집 잔기들 모두를 실험적으로 검증할 수 없기 때문에 이를 걸러내기 위한
전산학적 모델이 요구된다. RDDpred는 RNA 시퀀싱 데이터로부터 RNA 편집
현상을 검출하는 과정에서 발생하는 위양성 잔기들을 기계학습 기술에 기반하여
구분하는 모델이다. RDDpred는 두 개의 기 발표된 RNA 편집 연구 데이터를
이용하여 검증되었다.
RNA시퀀싱기술이활용될수있는또하나의복잡한문제로접합체차원에서
의 종양 이질성 (ITH) 측정 문제가 있다. ITH는 암 조직을 구성하는 세포 집단의
다양성의 지표이며, 최근 출판된 연구들의 결과는 유전자 발현량 데이터에 기반
하여 측정된 전사체 수준에서의 ITH가 암 환자의 예후예측에 유용함을 시사한다.
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접합체는 유전자 발현량과 함께 전사체를 구성하는 주요 요소 중 하나이며 따라서
접합체 수준에서 ITH를 측정하는 것은 보다 전체적인 수준에서 전사체 ITH를
연구하기 위한 자연스러운 흐름이다. RNA 시퀀싱 데이터를 이용하여 암 접합체
수준에서 ITH를 측정하는 과정에는 복잡한 접합 패턴과 광범위한 인트론 연장 변
이 및 짧은 시퀀싱 판독 길이 등의 심각한 기술적 난관들이 있다. SpliceHetero는
이러한 문제들을 고려하여 접합체 수준에서의 ITH (즉, sITH)를 측정하기 위한
도구이며 내부적으로 정보이론을 활용한다. SpliceHetero는 시뮬레이션 데이터,
이종이식 종양 데이터 및 TCGA pan-cancer 데이터 등을 활용하여 광범위하게
검증되었으며 ITH를 잘 반영하는 것으로 확인되었다. 이뿐 아니라 sITH는 암의
진행과 암 환자의 예후 및 PAM50와 같은 잘 알려진 분자 아형들과도 높은 상관
관계를 가지는 것으로 확인되었다.
마지막 연구 주제는 유전자 발현량 데이터에 기반하여 특정 암 표현형에 특
이적인 환자 부분 공간을 정의하는 기계학습 알고리즘을 개발하는 것이다. RNA
시퀀싱 데이터는 암 환자의 유전자 발현량 프로파일을 얻는 데에 유용한 도구이지
만, 2만개이상의차원을가진매우고차원의데이터이기때문에실질적인용도로
사용되기 위해서는 그 차원의 크기를 축소할 필요가 있다. 이때 각 유전자들은
복잡하지만 고유한 방식으로 서로 상호작용한다는 점을 이용할 수 있다. 실험적으
로 검증된 단백질 간의 상호작용 정보를 모아 네트워크 형태로 묶은 것을 단백질
상호작용 네트워크 (혹은 PIN)라 부른다. 이 PIN을 활용하여 RNA 시퀀싱 데이
터의 차원을 줄이면서도 데이터로부터 생물학적으로 유의미한 특징들을 추출할
수 있다. Tumor2Vec은 이렇게 추출된 PIN 수준의 특징들을 활용하여 특정 암
표현형에 특이적인 환자 부분 공간을 정의한다. Tumor2Vec은 조기 구강 암에서
림프절 전이를 예측하기 위한 파일럿 연구에 적용되었으며 그 결과 RNA 시퀀싱
데이터의차원을줄여림프절전이예측모델을생성했고이과정에서암표현형을
잘 설명하는 PIN 수준의 특징들을 보존하는 데에도 성공했다.
주요어: RNA 시퀀싱, RNA 편집, 선택적 접합, 유전자 발현, 기계학습, 정보이론,
그래프 임베딩, 차원 축소, 오토인코더
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